deltatrials
Completed PHASE2 INTERVENTIONAL NCT00207844

Selenium, as Sodium Selenite, in the Treatment of Septic Shock

Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of a Therapeutic Administration of Selenium, as Selenite, in Septic Shock Patients.

Sponsor: Centre Hospitalier de Meaux

Conditions Septic Shock Severe Sepsis
Interventions Selenium as sodium selenite
Updated 4 times since 2017 Last updated: Sep 13, 2005 Started: Jan 31, 2002 Completion: Jan 31, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Septic Shock and Severe Sepsis, this trial is completed. The trial is conducted by Centre Hospitalier de Meaux and has accumulated 4 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jan 2021 · 48 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE2

    First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier de Meaux
  • Ministry of Health, France
Data source: Centre Hospitalier de Meaux

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations